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Background and purpose: The outcome in acute stroke strongly depends on patient-related
issues, as well as on the availability of human and diagnostic resources. Our aim was to
evaluate safety and effectiveness of intravenous alteplase for stroke according to the time of
admission to the hospital.
Materials and methods: We analyzed the data of all acute stroke patients treated with alteplase
between October 2003 and December 2010, contributed to the Safe Implementation of Throm-
bolysis for Stroke registry from 27 Polish stroke centers. According to the time of admission we
distinguished between: (1) non-working days (Friday 14:30–Monday 08:00 plus national holi-
days); (2) out-of-ofﬁce hours (non-working days plus 14:30–08:00 during working days); and (3)
night hours (time from 23:00 to 06:00). Patients admitted during regular working hours
(Monday 08:00–Friday 14:30, excluding national holidays) were used as the reference.
Results: Of 1330 patients, 448 (32.5%) were admitted on non-working days, 868 (65.3%) at out-of-
ofﬁce hours, and 105 (7.9%) during night hours. In multivariate logistic regression, none of the
evaluated periods showed association with symptomatic intracranial hemorrhage, 7-day
mortality, and neurological improvement 4 points in the National Institutes of Health Stroke
Scale score at day 7. Patients admitted during night hours had lower odds (OR 0.53, 95% CI: 0.29–
0.95, p = 0.032) for achieving favorable outcome (modiﬁed Rankin Scale score 0–2).
Conclusions: There is no bad time for thrombolysis. Stroke centers should feel conﬁdent
about the treatment outside regular working hours, irrespective of equipment and staff
availability. However, it may be reasonable to pay additional attention during nighttime.
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Treatment with recombinant tissue plasminogen activator
(rtPA, alteplase) within the ﬁrst 4.5 h from the onset of
symptoms is currently the gold standard of stroke care in
developed countries [1–3]. Its effectiveness and safety depend
not only on patient-related issues, but also on human and
diagnostic resources. As the availability of those resources is not
equal 24 h a day and 7 days a week (24/7), the time of admission
may affect both the quality of care and the ﬁnal outcome [4,5].
Several studies have described the so-called 'weekend
phenomenon' [5–12]. Some authors also suggest that patients
admitted during out-of-ofﬁce hours [13,14] or night hours
[7,15,16] may achieve less favorable outcome. However, the
amount of evidence is still not sufﬁcient, especially regarding
treatment with rtPA. In Poland, the weekend phenomenon has
been previously addressed only in one study that included
unselected ischemic stroke patients, and did not account for
thrombolysis [12].
The aim of our study was to evaluate safety and effective-
ness of intravenous rtPA for ischemic stroke depending on the
time of admission to the hospital, including out-of-ofﬁce
hours, non-working days and night hours. Additional empha-
sis was put on the treatment logistics.
2. Materials and methods
We analyzed the data of all acute stroke patients treated with
intravenous rtPA between October 2003 and December 2010
contributed to the Safe Implementation of Treatments in
Stroke – Eastern Europe (SITS-EAST) registry by 27 Polish stroke
centers.
SITS-EAST is an international study of implementation of
evidence-based stroke therapy supported by the SITS Interna-
tional Registry of Thrombolysis in Stroke (SITS-ISTR). The
details of the SITS methodology, rationale for SITS-EAST and
Polish participation in the registry have been described in
detail elsewhere [17–19]. Brieﬂy, SITS was originally a Europe-
an Union-based, multinational, academic-driven, monitoring
study designed to conﬁrm the safety and effectiveness of
thrombolysis in clinical practice [20]. Despite achieving its
original aim in 2006, the registry as a platform has been
constantly expanding. Currently, it is the largest source of data
about licensed thrombolysis for stroke.
The registry in Poland has been approved by the local Ethics
Committee. Data for the present analysis were acquired in
August 2011 with the approval of the National Coordinator
(Prof. Anna Czlonkowska). To ensure completeness of the 3-
month follow-up, we decided not to include patients treated in
the year 2011.
According to the time of admission, we distinguished
between: (1) non-working days – deﬁned as Friday 14:30–
Monday 08:00 plus national holidays; (2) out-of-ofﬁce hours –
deﬁned as non-working days plus hours 14:30–08:00 during the
working days; and (3) night hours – deﬁned as the time from
23:00 to 06:00.
Our major endpoints were the following: (1) symptomatic
intracranial hemorrhage (sICH) according to the ECASS IIdeﬁnition (i.e. any intracranial hemorrhage combined with
National Institutes of Health Stroke Scale [NIHSS] score
worsening of 4 points or leading to death within 7 days);
(2) 7-day mortality; (3) signiﬁcant neurological improvement (i.
e. improvement of 4 points on the NIHSS or achieving the
NIHSS score of 0); (4) favorable outcome at 3-month follow-up
(i.e. modiﬁed Rankin Scale [mRS] score of 0–2 points, meaning
alive and independent) [21]. The ECASS II deﬁnition of sICH
was chosen because it allows to effectively predict the worst
outcome after thrombolysis [22]. As the measures of treatment
logistics, we used onset-to-treatment time (OTT), and door-to-
needle time (DNT) with special emphasis on DNT 60 min.
2.1. Statistical analysis
Categorical variables are presented as a number of valid
observations with ratio. Proportions were calculated with
exclusion of unknown values from the denominator. Due to
non-normal distribution, continuous variables are presented
as a median with interquartile range (IQR, representing 50% of
average observations surrounding the median).
All analyses were made using regular working hours
(Monday 08:00–Friday 14:30, excluding national holidays) as
a reference. For basic comparisons, we used x2 test (with Yates
correction if the expected value in at least one cell of a 2  2
contingency table was <5) or Mann–Whitney U-test. To
calculate odds ratios (OR) with 95% conﬁdence interval (95%
CI) for each primary endpoint, we used multivariable logistic
regression. All regression models were arbitrarily adjusted for
age, lack of prestroke disability (mRS score 1), baseline NIHSS
score, and OTT 90 min.
Calculations were carried out in STATISTICA 10.0 (Stat Soft
Inc., Tulsa, USA, 2011). We considered a p-value <0.05
statistically signiﬁcant. In tables, p-values >0.100 are pre-
sented as non-signiﬁcant (NS).
3. Results
In the study period, 1330 cases of intravenous thrombolysis
were reported to the registry, including 868 (65.3%) patients
admitted at out-of-ofﬁce hours, 448 (32.5%) admitted on non-
working days, and 105 (7.9%) admitted during night hours. The
reference group consisted of 462 patients admitted during
regular working hours (Fig. 1).
3.1. Out-of-ofﬁce hours
Patients admitted at out-of-ofﬁce hours did not differ from the
patients admitted during working hours in terms of distribu-
tion of vascular risk factors, but more frequently presented
with no preexisting disability (92.9% vs. 88.2%, p = 0.004). They
had a signiﬁcantly lower proportion of mild strokes (NIHSS
score 7) and more frequently showed hyperdense artery sign
on the pretreatment brain computed tomography (CT)
(Table 1). We found no differences in the median OTT and
DNT, but patients admitted at out-of-ofﬁce hours less
frequently received thrombolysis within the ﬁrst 90 min from
the onset of symptoms (7.3% vs. 12.1%, p = 0.003) (Table 1).
The occurrence of sICH, neurological worsening and the
Fig. 1 – Groups of patients according to the time of admission. rtPA – recombinant tissue plasminogen activator.
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the groups (Table 2; Fig. 2). In a multivariate analysis (adjusted
for age, lack of prestroke disability, baseline NIHSS score and
OTT 90 min), the admission out-of-ofﬁce hours showed no
association with major endpoints (Table 3).Table 1 – Baseline characteristics using regular hours admissio
Regular hours Out-of-ofﬁce hou
N Value N Value 
Age (years) 462 69 (60–76) 868 68 (59–76) 
Male gender 462 260 (56.3%) 868 494 (56.9%) 
Hypertension 456 331 (72.6%) 855 623 (72.9%) 
Diabetes 459 80 (17.4%0 857 149 (17.4%) 
Hyperlipidaemia 412 152 (36.9%) 797 257 (32.3%) 
Atrial ﬁbrillation 457 145 (31.7%) 853 264 (31.0%) 
Congestive heart failure 454 83 (18.3%) 851 158 (18.6%) 
Prior stroke 460 62 (13.5%) 864 106 (12.3%) 
Prestroke antiplatelet use 461 153 (33.2%) 864 263 (30.4%) 
No prestroke disability
(mRS 1)
448 385 (88.2%) 835 776 (92.9%) 
Stroke severity (NIHSS) 459 11 (7–17) 866 12 (8–16) 
- Mild (NIHSS 7) 459 129 (28.1%) 866 199 (23.0%) 
- Moderate (NIHSS 8–14) 459 163 (35.5%) 866 350 (40.4%) 
- Severe (NIHSS 15) 459 167 (36.4%) 866 317 (36.6%) 
Hyperdense artery
sign on CT
448 44 (9.8%) 842 120 (14.3%) 
Systolic blood pressure
(mm Hg)
459 150 (138–165) 863 150 (140–165) 
Diastolic blood pressure
(mm Hg)
459 85 (80–90) 863 85 (80–93) 
Intravenous antihyper-
tensives
445 33 (7.4%) 836 59 (7.1%) 
Blood glucose (mg/dL) 443 120 (103–149) 843 121 (107–142) 
Data are presented as number of observations (ratio) or median (interqu
mRS – modiﬁed Rankin Scale, NIHSS – National Institutes of Health Stro3.2. Non-working days
Patients admitted on non-working days had a similar
distribution of vascular risk factors compared to patients
admitted during regular hours. They more frequentlyns as a reference.
rs Non-working days Night hours
p N Value p N Value p
NS 448 69 (60–76) NS 105 64 (54–72) <0.001
NS 448 258 (57.6%) NS 105 67 (63.8%) NS
NS 441 328 (74.4%) NS 104 64 (61.5%) 0.026
NS 441 70 (15.9%) NS 104 18 (17.3%) NS
NS 415 135 (32.5%) NS 96 30 (31.3%) NS
NS 440 135 (30.7%) NS 103 33 (32.0%) NS
NS 439 84 (19.1%) NS 103 16 (15.5%) NS
NS 444 60 (13.5%) NS 105 8 (7.6%) NS
NS 446 143 (32.1%) NS 105 32 (30.5%) NS
0.004 427 394 (92.3%) 0.042 99 93 (93.9%) 0.094
NS 447 12 (8–16) NS 105 13 (8–16) NS
0.040 447 102 (22.8%) 0.068 105 17 (16.2%) 0.012
0.081 447 184 (41.2%) 0.080 105 42 (40.0%) NS
NS 447 161 (36.0%) NS 105 46 (43.8%) NS
0.023 435 57 (13.1%) NS 104 16 (15.4%) NS
NS 447 150 (137–166) NS 103 150 (130–160) NS
NS 447 85 (80–90) NS 103 80 (75–92) NS
NS 430 33 (7.7%) NS 102 4 (3.9%) NS
NS 431 122 (108–145) NS 101 123 (114–136) NS
artile range).
ke Scale, CT – computed tomography.
Table 3 – Odds ratios (OR) for the primary endpoints calculated using multivariate logistic regression.
sICH according
to ECASS
Death at 7 days Signiﬁcant
improvement
Favorable outcome
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Evaluated variablesa
- Out-of-ofﬁce hours 0.86 (0.50–1.49) NS 1.08 (0.68–1.71) NS 0.82 (0.65–1.05) NS 0.90 (0.67–1.22) NS
- Non-working days 1.15 (0.64–2.07) NS 1.30 (0.77–2.17) NS 0.80 (0.61–1.06) NS 0.85 (0.60–1.20) NS
- Night hours 0.71 (0.21–2.48) NS 1.02 (0.41–2.52) NS 0.72 (0.45–1.14) NS 0.53 (0.29–0.95) 0.032
Covariables
- No prestroke
disability (mRS 1)
0.46 (0.23–0.93) 0.030 1.08 (0.53–2.20) NS 1.05 (0.69–1.59) NS 2.2 (1.3–3.8) 0.001
- Age (for each 5 years) 1.11 (0.91–1.26) NS 1.07 (0.96–1.19) NS 0.98 (0.93–1.03) NS 0.93 (0.86–0.99) 0.027
- Baseline NIHSS
(for each 4 points)
1.29 (1.07–1.55) 0.007 1.75 (1.48–2.06) <0.001 0.94 (0.86–1.02) NS 0.46 (0.41–0.51) <0.001
- Time to treatment
90 min
0.81 (0.31–2.10) NS 1.19 (0.59–2.43) NS 1.02 (0.68–1.51) NS 1.2 (0.7–1.92) NS
a Each multivariate model included one of the evaluated variables and was adjusted for all four covariables.
CI – confidence interval, ECASS – the European Cooperative Acute Stroke Study, mRS – modified Rankin Scale, NIHSS – National Institutes of
Health Stroke Scale, sICH – symptomatic intracranial hemorrhage.
Fig. 2 – The distribution of modified Rankin Scale (mRS) scores at the 3-month follow-up according to the time of admission.
Table 2 – Treatment logistics and outcome using regular hours admissions as a reference.
Regular hours Out-of-ofﬁce hours Non-working days Night hours
N Value N Value p N Value p N Value p
Onset-to-treatment
time (min)
462 150 (120–170) 867 150 (120–170) NS 448 148 (120–165) NS 105 150 (120–170) NS
- 90 min or less 462 56 (12.1%) 867 63 (7.3%) 0.003 448 30 (6.7%) 0.005 105 8 (7.6%) NS
Door-to-needle time
(min)
462 75 (54–103) 867 72 (55–97) NS 448 70 (53–95) NS 105 76 (59–90) NS
- 60 min or less 462 160 (34.6%) 867 300 (34.6%) NS 448 167 (37.3%) NS 105 32 (30.5%) NS
sICH according to
ECASS II def.
455 24 (5.3%) 847 39 (4.6%) NS 443 26 (5.9%) NS 105 3 (2.9%) NS
Outcome at day 7
- Improvement 4
on NIHSS
445 279 (62.7%) 837 481 (57.5%) NS 435 243 (55.9%) 0.039 98 56 (57.1%) NS
- Worsening 4
on NIHSS
445 53 (11.9%) 837 104 (12.4%) NS 435 61 (14.0%) NS 98 12 (12.2%) NS
- Death 458 34 (7.4%) 837 66 (7.7%) NS 446 41 (9.2%) NS 103 7 (6.8%) NS
Outcome after 3 months
- Excellent (mRS 0–1) 353 124 (35.1%) 683 244 (35.7%) NS 363 128 (35.3%) NS 76 22 (29.0%) NS
- Favorable (mRS 0–2) 353 188 (53.3%) 683 357 (52.3%) NS 363 184 (50.7%) NS 76 32 (42.1%) 0.078
Death 355 63 (17.8%) 685 132 (19.3%) NS 364 74 (20.3%) NS 76 14 (18.4%) NS
Data are presented as number of observations (ratio) or median (interquartile range), sICH – symptomatic intracranial hemorrhage.
mRS – modiﬁed Rankin Scale, ECASS II – the European Cooperative Acute Stroke Study II, NIHSS – National Institutes of Health Stroke Scale.
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p = 0.042) and tended to have a lower proportion of mild
strokes (Table 1). Despite similar median OTT, they were less
frequently treated within the ﬁrst 90 min from the onset of
symptoms (6.7% vs. 12.1%, p = 0.003). There were no differ-
ences in the occurrence of sICH, neurological worsening and
the distribution of the 3-month mRS scores (Table 2; Fig. 2).
Patients admitted on non-working days less frequently
achieved neurological improvement (55.9% vs. 62.7%,
p = 0.039), but this association was not conﬁrmed after
adjustment for age, lack of prestroke disability, baseline
NIHSS score and OTT 90 min (Table 3).
3.3. Night hours
In comparison to the group admitted during regular working
hours, patients admitted during nighttime were younger
(median 64 vs. 69 years, p < 0.001) and less frequently had a
history of hypertension (61.5% vs. 72.6%, p = 0.026). Despite
similar median stroke severity, they had a lower proportion of
mild strokes (Table 1). There were no differences in OTT, DNT,
the rate of sICH, neurological improvement and mortality
(Table 2). However, the proportion of patients with no residual
deﬁcit (mRS 0) after 3 months was lower in patients admitted
during night hours (6.6% vs. 15.3%, p = 0.045) (Fig. 2). The
tendency for lower rate of favorable outcome became signiﬁ-
cant after adjustment for age, lack of prestroke disability,
baseline NIHSS score, and OTT 90 min (OR 0.53, 95% CI: 0.29–
0.95) (Tables 2 and 3).
4. Discussion
In Poland, intravenous thrombolysis started in October 2003.
Since then, many Polish stroke centers have voluntarily joined
the SITS registry. Participation in stroke registries is also
recommended by the national guidelines [1]. Thrombolysis
was initially funded by The National Program for Prevention and
Treatment of Cardiovascular Diseases – POLKARD [23]. In 2009,
alteplase became reimbursed for stroke by the National Health
Fund and the original 3-hour time window was extended to 4.5 h
in autumn 2010 [24]. Although the organization of Polish stroke
care has been constantly improving [25], the relatively high 3-
month mortality rate after thrombolysis [26] reminds that there
is still much to be done.
To our knowledge, this is the ﬁrst nationwide study that
uses multivariate methodology and a common reference (i.e.
admissions during regular working hours) to simultaneously
evaluate the safety, effectiveness and logistics of intravenous
thrombolysis for stroke in patients admitted during out-of-
ofﬁce hours, non-working days, and night hours.
Weekend hospital admissions increase the risk of death in
both emergency and elective patients [27], including those in
intensive care units (ICU) [28]. However, the ICU mortality of
nighttime admissions does not seem to exceed the mortality of
daytime admissions [28]. In stroke, the time of onset of
symptoms shows a circadian pattern with the highest
occurrence in the morning, which may partially explain the
low proportion of nighttime admissions [29]. A post hoc
analysis of the National Institute of Neurological Disorders andStroke (NINDS) trial showed that the beneﬁt from intravenous
thrombolysis did not depend on the time of stroke onset.
However, the rate of sICH was the highest in patients who had
stroke between 00.00 and 04.00 h [15]. According to our
ﬁndings, patients admitted at out-of-ofﬁce hours and on
non-working days appear to be very similar to patients
admitted during regular working hours, both in terms of
baseline characteristic and outcome. The tendency for a lower
proportion of mild strokes may correspond with the higher
proportion of the hyperdense artery sign, but it does not seem
to modify the effect of thrombolysis.
According to a large multicenter study conducted in the
USA between 2003 and 2007, stroke patients admitted at out-
of-ofﬁce hours had higher in-hospital morality, despite only
minor differences in the quality of care [13]. Studies comparing
thrombolysis administered out-of-ofﬁce hours and during
regular hours agree on the similar baseline characteristics of
patients, but provide conﬂicting results on mortality [14,30].
Stroke patients admitted at weekends are also less likely to
receive care in line with the current guidelines [5]. Compared
to weekday admissions, their thrombolysis rate tends to be
lower [6–8,31,32] and the outcome is either similar [6,7,31,32] or
worse [8–11]. In Poland, the weekend phenomenon has been
addressed in a large analysis of 19 667 unselected ischemic
stroke patients admitted between June 2004 and June 2005 to
78 centers participating in the POLKARD Hospital Stroke
Registry [12]. In comparison to weekday admissions, patients
admitted at the weekends had increased early mortality and a
higher rate of combined early mortality and dependency.
Thrombolysis was not addressed in this study, because at that
time it was rarely used (<1% of ischemic stroke patients
nationwide). However, studies concentrating on patients
treated with rtPA show no deleterious effect of the weekend
admission on outcome, which is also conﬁrmed by our
analysis [7,31].
Strokes occurring during sleep are usually more severe and
have worse outcome than other strokes [33,34]. In our
material, patients admitted at nighttime were younger, more
frequently without preexisting disability, and without hyper-
tension. However, they were less likely to achieve favorable 3-
month outcome. Previous studies agree on the younger age
[7,16]. It has been also suggested that stroke patients treated
with rtPA during night hours have a higher rate of sICH [16]
despite fewer vascular risk factors or they are less frequently
discharged in a good clinical state [7]. On the whole, it may be
advisable to pay more attention to patients admitted at
nighttime, but there is no reason to refrain from thrombolysis
in eligible cases.
In comparison to patients admitted during regular hours,
the proportions of those treated within 90 min from the stroke
onset were lower in all evaluated groups. Considering the
similar rate of DNT 60 min, it may be assumed that increased
delays were most likely due to prolonged prehospital phase. It
concurs with a post hoc analysis of the NINDS trial, showing
that patients with the onset of symptoms between 00.00 and
06.00 h are less likely to be treated within 90 min [15]. However,
an analysis of the circadian variation of thrombolysis in the
SITS-EAST population by Korv et al. [16] demonstrated that
both mean OTT and mean DNT were about 10 minutes longer
in the nighttime strokes.
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The study is based on data from a voluntary registry of stroke
patients treated with rtPA. Therefore, it was not possible to
determine the reasons for missing data, to establish the rate of
thrombolysis in particular time periods or to identify factors
deterring the physician on duty from administering rtPA. We
may also not exclude a selection bias. However, the rate of
patients admitted between 23.00 and 06.00 h is similar to the
rate observed in the NINDS trial [15] and a German stroke
registry [7]. To minimize the inﬂuence of confounders, we used
multivariate logistic regression adjusted for age, lack of
prestroke disability, baseline NIHSS score, and OTT 90 min.
On the contrary, the registry reﬂects real life clinical practice of
Polish stroke centers.
5. Conclusions
1. There is no such thing as a bad time for intravenous
thrombolysis.
2. The safety and effectiveness of thrombolysis seem not to
depend on the time of admission and associated disparities
in the availability of additional diagnostic equipment and
experienced staff. All stroke units in Poland should feel
conﬁdent about applying the treatment nonstop 24/7.
3. It may be reasonable to pay more attention to patients
admitted at nighttime.
4. It is necessary to increase the thrombolytic awareness in
patients and ambulance staff to shorten the prehospital
delays during the non-regular working hours.
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Appendix
The following centers from the SITS Poland Collaborative
Group contributed to this study (name of the hospital and the
local coordinator with the number of included patients):II Klinika Neurologiczna IPiN, Warsaw (A. Kobayashi – 301),
SP ZZOZ in Sandomierz (P. Sobolewski – 162); Szpital
Uniwersytecki nr 2, Bydgoszcz (P. Lisewski – 142); Wojewódzki
Zespół Neuropsychiatryczny, Opole (S. Romanowicz – 123);
Pomorskie Centrum Traumatologii, Gdańsk (W. Fryze – 108);
Uniwersyteckie Centrum Kliniczne, Gdańsk (W. Nyka – 69);
Szpital Wojewódzki nr 2, Rzeszów (M. Zięba – 63); CSK MSWiA,
Warszawa (M. Dorobek – 55); Szpital Wolski, Warszawa (A.
Kuczyńska-Zardzewiały – 45); Szpital Specjalistyczny, Końskie
(M. Fudała – 43); SP CSK SUM, Katowice (G. Opala – 42); Szpital
Specjalistyczny, Piła (M. Wiszniewska – 36); Szpital Powiatowy,
Skarżysko-Kamienna (J. Stoiński – 35); Wojewódzki Szpital
Podkarpacki, Krosno (R. Jucha – 20); Szpital Specjalistyczny,
Siedlce (P. Kwiatkowski – 20); Wojewódzki Szpital Zespolony,
Konin (H. Krupczyńska – 20), Szpital Kolejowy, Pruszków (J.
Pniewski – 15); I Klinika Neurologiczna IPiN, Warszawa (P.
Richter – 12); Szpital Wojewódzki, Poznań (J.Michalska – 11);
Szpital Specjalistyczny, Kościerzyna (A. Walczak – 9); Uni-
wersytecki Szpital Kliniczny, Białystok (W. Drozdowski – 9),
Szpital Powiatowy, Ostrowiec Świętokrzyski (A. Wesek – 8); SP
CSK WUM, Warszawa (H. Kwiecińskiy – 7); WIM, Warszawa (J.
Stępień – 1); Dolnośląski Szpital Specjalistyczny, Wrocław (K.
Gurański – 4); Wojewódzki Specjalistyczny Zespół Opieki
Zdrowotnej, Kielce (H. Prędota-Panecka – 3), Wojewódzki
Szpital Specjalistyczny, Olsztyn (A. Tutaj – 1).
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